Search for: "Pharmaceutical Generic Developers, Inc." Results 81 - 100 of 1,119
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2022, 10:03 am by Robert B. Milligan
In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. [read post]
25 May 2022, 2:26 am by Matrix Legal Support Service
The CAT has developed a sophisticated and consistent approach to costs awards so that the parties know what to expect if they win or lose the case. [read post]
24 May 2022, 4:23 pm by Bill Marler
We have included this timeline in Appendix A, and we have processes under review to develop better systems within FDA. [read post]
26 Apr 2022, 3:48 pm by luiza
  Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. [read post]
8 Apr 2022, 2:05 am by Editors
Counsel/Corporate Counsel, Commercial Transactions/Strategic Partnerships, Roofstock (San Francisco, CA) Associate General Counsel – Global Head of IP, www.princetonlegal.com (Princeton, NJ) AGC – Rapidly Growing Startup Healthcare Company, Beacon Hill Staffing Group (Boston, MA) In-House Corporate Counsel (full-time remote engagement), Latitude (New York, NY) Legal Counsel & Global Copyright Manager, Christie’s (New York, NY) Director, Corporate Counsel –… [read post]
29 Mar 2022, 5:04 pm by Cynthia Marcotte Stamer
Solutions Law Press, Inc. invites you receive future updates by registering on our Solutions Law Press, Inc. [read post]
19 Mar 2022, 2:09 pm by admin
The FDA acknowledges, for instance, that the acceptable intake is set to mark “a small theoretical increase in risk,” and a “highly hypothetical concept that should not be regarded as a realistic indication of the actual risk,” and thus not an actual risk.[9] The corresponding hypothetical or theoretical risk to the acceptable intake level is clearly small when compared with the human’s lifetime probability of developing cancer (which the FDA states is greater… [read post]
9 Mar 2022, 7:47 pm by Cynthia Marcotte Stamer
Public companies and other market participating or influencing companies and their leaders should begin preparing to comply with enhanced cybersecurity risk management, disclosure, strategy, governance and incident reporting and response requirements of a Proposed Rule the Security and Exchange Commission (“SEC”) published in today’s (March 9, 2022) Federal Register. [read post]
3 Mar 2022, 9:32 pm by Cynthia Marcotte Stamer
Department of Justice along with the Minnesota and New York Attorneys General (collectively “Justice Department”) have filed a civil antitrust lawsuit to stop UnitedHealth Group Incorporated (“United”) from acquiring Change Healthcare Inc. [read post]
26 Feb 2022, 6:53 pm by admin
” Its charge was “to develop thoughtful principles and practices that the ASA can endorse and share with scientists and journal editors. [read post]
16 Feb 2022, 5:01 am by Chris Jay Hoofnagle, Simson Garfinkel
This was an exciting development because it was previously thought that annealing quantum computers could not factor. [read post]
1 Feb 2022, 4:08 pm by Ben Vernia
The civil settlement also resolved allegations that Purdue paid kickbacks to doctors, certain specialty pharmacies and an electronic health records developer to increase prescriptions of Purdue’s opioid products. [read post]
1 Feb 2022, 12:32 am by Roel van Woudenberg
Regele dated 16 January 2017D50 Assignment by the inventors to Alexion Pharmaceuticals Inc. dated 28.03.2007, 02.04.2007 and 11.09.2007 respectivelyD51 Document supporting the name change from "UDEC Pharmaceuticals,Inc. to "Alexion Pharmaceuticals Inc"D52 Declaration of S. [read post]
13 Jan 2022, 1:55 am by Kevin Kaufman
Pharmaceutical companies, for instance, may spend years investing hundreds of millions of dollars developing and testing a new drug before completing a viable product approved for public use. [read post]
11 Jan 2022, 11:45 am by luiza
Here are the top ten healthcare recoveries of 2021 by the numbers: Generic Drug Price-Fixing – in October, three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz and Apotex Corporation, agreed to pay $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]